MeiraGTx Holdings (MGTX) Total Non-Current Liabilities (2017 - 2025)

MeiraGTx Holdings (MGTX) posted Total Non-Current Liabilities of $248.8 million for Q4 2025, up 8.82% on a QoQ basis from $228.7 million in Q3 2025, and up 24.97% year-over-year from $199.1 million in Q4 2024.

MeiraGTx Holdings (MGTX) Total Non-Current Liabilities (2017 - 2025) Analysis & Trends

MeiraGTx Holdings' Total Non-Current Liabilities history runs 9 years deep, the most recent figure standing at $248.8 million for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 24.97% year-over-year to $248.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $248.8 million (up 24.97% YoY) and the FY2025 annual result came in at $248.8 million, up 24.97% from the prior year.
  • Total Non-Current Liabilities was $248.8 million for Q4 2025 at MeiraGTx Holdings, up from $228.7 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $248.8 million in Q4 2025 and bottomed at $108.4 million in Q2 2022.
  • A 5-year average of $173.0 million and a median of $184.7 million in 2023 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Total Non-Current Liabilities slipped 9.03% — and 2023, when it soared 70.16%.
  • MeiraGTx Holdings' Total Non-Current Liabilities stood at $132.7 million in 2021, then soared by 49.47% to $198.3 million in 2022, then retreated by 6.13% to $186.2 million in 2023, then increased by 6.95% to $199.1 million in 2024, then increased by 24.97% to $248.8 million in 2025.
  • Business Quant data shows MGTX's Total Non-Current Liabilities at $248.8 million in Q4 2025, $228.7 million in Q3 2025, and $194.3 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 4.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 110.28 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.98 Bn
4 NuCana 279.75 Bn 279.75 Bn - 949,738.67
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.87 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 7.32 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 40.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 746.94 Mn
10 MeiraGTx Holdings 973.21 Mn 907.27 Mn - 248.82 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 248.82 Mn
Sep 30, 2025 228.66 Mn
Jun 30, 2025 194.30 Mn
Mar 31, 2025 189.57 Mn
Dec 31, 2024 199.10 Mn
Sep 30, 2024 200.87 Mn
Jun 30, 2024 184.12 Mn
Mar 31, 2024 185.06 Mn
Dec 31, 2023 186.17 Mn
Sep 30, 2023 172.99 Mn
Jun 30, 2023 184.44 Mn
Mar 31, 2023 195.68 Mn
Dec 31, 2022 198.32 Mn
Sep 30, 2022 176.66 Mn
Jun 30, 2022 108.39 Mn
Mar 31, 2022 124.30 Mn
Dec 31, 2021 132.68 Mn
Sep 30, 2021 113.58 Mn
Jun 30, 2021 119.15 Mn
Mar 31, 2021 117.03 Mn